120 related articles for article (PubMed ID: 9455766)
1. Atrial flutter in a pediatric patient in the immediate period after the Fontan procedure: control with oral propafenone.
Herzberg GZ; Rossi AF
Pacing Clin Electrophysiol; 1997 Dec; 20(12 Pt 1):3002-3. PubMed ID: 9455766
[TBL] [Abstract][Full Text] [Related]
2. Clinical comparison of ibutilide and propafenone for converting atrial flutter.
Sun JL; Guo JH; Zhang N; Zhang HC; Zhang P
Cardiovasc Drugs Ther; 2005 Jan; 19(1):57-64. PubMed ID: 15883757
[TBL] [Abstract][Full Text] [Related]
3. Atrial flutter termination by overdrive transesophageal pacing and the facilitating effect of oral propafenone.
Doni F; Della Bella P; Kheir A; Manfredi M; Piemonti C; Staffiere E; Rimondini A; Fiorentini C
Am J Cardiol; 1995 Dec; 76(17):1243-6. PubMed ID: 7503004
[TBL] [Abstract][Full Text] [Related]
4. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
[TBL] [Abstract][Full Text] [Related]
5. Type II atrial flutter interruption with transesophageal pacing: use of propafenone and possible change of the substrate.
Doni F; Staffiere E; Manfredi M; Piemonti C; Todd S; Rimondini A; Fiorentini C
Pacing Clin Electrophysiol; 1996 Nov; 19(11 Pt 2):1958-61. PubMed ID: 8945077
[TBL] [Abstract][Full Text] [Related]
6. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
[TBL] [Abstract][Full Text] [Related]
7. Management of atrial flutter after the Fontan procedure.
Balaji S; Johnson TB; Sade RM; Case CL; Gillette PC
J Am Coll Cardiol; 1994 Apr; 23(5):1209-15. PubMed ID: 8144791
[TBL] [Abstract][Full Text] [Related]
8. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
Zhang HC; Guo JH; Fang Q; Zheng YA; Sun YM; Zhu WQ; Wan Z; Guo JX; Ge JB; Han SM
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):798-801. PubMed ID: 15949393
[TBL] [Abstract][Full Text] [Related]
9. Safety and tolerability of long-term propafenone therapy for supraventricular tachyarrhythmias. The Propafenone Multicenter Study Group.
Podrid PJ; Anderson JL
Am J Cardiol; 1996 Aug; 78(4):430-4. PubMed ID: 8752188
[TBL] [Abstract][Full Text] [Related]
10. Improved Ventricular Function after TEE-guided Cardioversion of Atrial Arrhythmias in Patients after the Fontan Operation.
Poterucha JT; Egbe AC; Johnson JN; Niaz T; Wackel PL; Cannon BC; Eidem BW; Cetta F
Congenit Heart Dis; 2016 Dec; 11(6):578-583. PubMed ID: 27030521
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation of "class IC atrial flutter" in patients with resistant atrial fibrillation.
Nabar A; Rodriguez LM; Timmermans C; Smeets JL; Wellens HJ
Am J Cardiol; 1999 Mar; 83(5):785-7, A10. PubMed ID: 10080440
[TBL] [Abstract][Full Text] [Related]
12. Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias.
Rae AP
Am J Cardiol; 1998 Oct; 82(8A):59N-65N. PubMed ID: 9809902
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone.
Fragakis N; Papadopoulos N; Papanastasiou S; Kozirakis M; Maligkos G; Tsaritsaniotis E; Katsaris G
Pacing Clin Electrophysiol; 2005 Sep; 28(9):954-61. PubMed ID: 16176535
[TBL] [Abstract][Full Text] [Related]
14. New onset atrial flutter termination by overdrive transoesophageal pacing: effects of different protocols of stimulation.
Doni F; Manfredi M; Piemonti C; Staffiere E; Todd S; Rimondini A; Fiorentini C
Europace; 2000 Oct; 2(4):292-6. PubMed ID: 11194595
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group.
Aliot E; Denjoy I
Am J Cardiol; 1996 Jan; 77(3):66A-71A. PubMed ID: 8607394
[TBL] [Abstract][Full Text] [Related]
16. Safety of oral propafenone in the treatment of arrhythmias in infants and children (European retrospective multicenter study). Working Group on Pediatric Arrhythmias and Electrophysiology of the Association of European Pediatric Cardiologists.
Janousek J; Paul T
Am J Cardiol; 1998 May; 81(9):1121-4. PubMed ID: 9605053
[TBL] [Abstract][Full Text] [Related]
17. [Late supraventricular arrhythmia complicating Fontan or cavopulmonary type procedures. Apropos of 7 cases].
Maragnès P; Villain E; Iselin M; David N; Foucault JP
Arch Mal Coeur Vaiss; 1996 May; 89(5):605-9. PubMed ID: 8758570
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacological cardioversion of atrial fibrillation with intravenous and oral propafenone].
Peciuliene I; Lukoseviciūte A
Medicina (Kaunas); 2002; 38(12):1212-6. PubMed ID: 12552163
[TBL] [Abstract][Full Text] [Related]
19. Intravenous amiodarone versus propafenone for atrial fibrillation and flutter after cardiac surgery: a note of caution.
Carrel T; Meyer B; Candinas R; Turina M; Schmid ER
Eur J Cardiothorac Surg; 1996; 10(12):1144-6. PubMed ID: 10369653
[No Abstract] [Full Text] [Related]
20. [Facilitating effect of propafenone pretreatment in the interruption of atrial flutter by transesophageal pacing].
Doni F; Kheir A; Manfredi M; Piemonti C; Staffiere E; Todd S; Rimondini A
Cardiologia; 1996 Feb; 41(2):135-40. PubMed ID: 8674092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
